Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR TEA: Tirofiban in Acute Ischemic Stroke Patients Treated With Intravenous Alteplase Thrombolysis
NCT03357133Phase 3Terminated
- Sponsor
- Capital Medical University
- Start
- Dec 2017
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban in ischemic stroke, sponsored by Capital Medical University. Started Dec 2017; status: terminated.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03357133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03357133.